Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
KAPA · NYSE · Pharmaceutical Preparations
$0.4359−0.0211 (−4.62%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Kairos Pharma (KAPA) · oqro.io/stocks/KAPA · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Insider trade · Traded Nov 25, 2024 · Filed Nov 26, 2024
Officer purchased ~$318 of KAPA shares in the open marketSourceInsider trade · Traded Nov 22, 2024 · Filed Nov 25, 2024
CFO purchased ~$3.8K of KAPA shares in the open marketSourceInsider trade · Traded Nov 20, 2024 · Filed Nov 22, 2024
CEO purchased ~$5.8K of KAPA shares in the open marketSource